Skip to main content
Home
language-selector-globe Korea | ko
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Korea
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • 회사소개 
      • 주요 전략 
      • 직원과 기업문화 
      • 다양성과 포용성 
      • 제품정보  
      • 노바티스그룹 경영진 
      • 핵심 사업부문 
      • 연락처 
      About Novartis Korea 회사소개
    • 환자와 보호자 
      • 환자와 보호자에 대한 노바티스의 약속 
      • 주요 질병 분야 
      • 제품정보  
      • 부작용 보고 
      A couple holding hands 환자와 보호자
    • 의료전문가 
      • 메드허브 
      • 제품정보  
      • 부작용 보고 
      • 혁신 
      • 글로벌 정보서비스 
      Novartis Health Care 의료전문가
    • 혁신 
      • 임상시험 
      • 기술 플랫폼 
      • 데이터와 디지털 
      • 한국노바티스의 혁신 
      • 노바티스의 혁신 
      • 노바티스 생명의학연구소(NIBR) 
      Novartis Innovation 혁신
    • 환경, 사회 및 가브넌스 
      • 윤리 위험 및 규정준수 
      • 의약품 접근성 
      • 환경지속가능성 
      • 글로벌 헬스 
      • 윤리적 행동양식 
      • 한국노바티스의 사회적 책임 
      Novartis ESG 환경, 사회 및 가브넌스
    • 뉴스룸 
      • 보도자료  
      • 이노베이션 스토리  
      • 자료실 
        • 의약품 회수에 관한 공표 
      Novartis News 뉴스룸
    • 인재채용 
      • 채용 공고 
      • 우리가 일하는 방식 
      • 웰빙 
      • 다양성과 포용성  
      • 수상내역 
      Novartis Careers 인재채용
    • Coronavirus 
      multiple coronavirus illustration edit image_1 코로나바이러스감염증-19 (COVID-19) 업데이트
    Seoul Skyline Home
  1. Home
  2. 인재채용
  3. 채용 공고
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Business Data Analyst II Hyderabad (Office) India Biomedical Research Data and Digital Sep 11, 2024
Clinical Data Specialist II Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist I Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
BR Submission Management, Lead Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
BR Submission Management, Specialist Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) India Biomedical Research Research & Development Aug 12, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Switzerland Legal Corporate Others Sep 26, 2024
Tax Manager (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 06, 2024
Investor Relations Executive Director East Hanover USA Finance Corporate Audit & Finance Aug 28, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Associate Director Compliance Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Jun 19, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Jun 20, 2024
Associate Director Data Science Hyderabad (Office) India Corporate Corporate Data and Digital Sep 19, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Sep 04, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Sep 04, 2024
Executive Director, Public Affairs LaCan Region East Hanover USA Corporate Affairs Corporate Communications & Public Affairs May 09, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compl. Aug 29, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Oct 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Oct 01, 2024
Associate Director, SUSE Linux Administrator Prague Czech Republic Operations Corporate Technology Transformation Sep 23, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 01, 2024
REFS Key Account & Business Relationship Manager Basel (City) Switzerland Operations CTS Facilities & Administration Aug 30, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Associate Director -Project Manager LDC Operations( SAP S4Hana SCM Applications) Hyderabad (Office) India Operations CTS Technology Transformation Sep 16, 2024
Strategic Design Commercial Contracts Manager Barcelona Gran Vía Spain Operations CTS Marketing Sep 24, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Regional Procurement Head REFS - US INSURGENTES Mexico Operations CTS Procurement Oct 04, 2024
Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Manager - Field Effectiveness Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
Buyer with German Prague Czech Republic Operations CTS Procurement Aug 23, 2024
Associate Director, Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 03, 2024
Director- Enterprise Architect(Architecture Design/Cross functional - SAP Implementation) Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Gbl Procurement Head IT Infra & Security Barcelona Gran Vía Spain People & Organization CTS Procurement Aug 27, 2024
Senior Process Excellence Specialist Prague Czech Republic Operations CTS Procurement Aug 27, 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

한국노바티스

Navigate Novartis
  • 회사소개
  • 환자와 보호자
  • 의료전문가
  • 혁신
  • 환경, 사회 및 가브넌스
  • 뉴스룸
  • 인재채용
Media Center
  • 보도자료
  • 이노베이션 스토리
Other Novartis Websites in Korea
  • MedHub
  • Novartis Global
  • 한국노바티스 LinkedIn
  • 한국노바티스 YouTube
Footer Bottom
© 2024 Novartis AG
  • 개인정보 처리방침
  • 이용약관
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
이 사이트는 국내 거주자들을 위한 사이트입니다. KR2205234431